190 related articles for article (PubMed ID: 34697698)
21. Cxcr4-haploinsufficient bone marrow transplantation corrects leukopenia in an unconditioned WHIM syndrome model.
Gao JL; Yim E; Siwicki M; Yang A; Liu Q; Azani A; Owusu-Ansah A; McDermott DH; Murphy PM
J Clin Invest; 2018 Aug; 128(8):3312-3318. PubMed ID: 29715199
[TBL] [Abstract][Full Text] [Related]
22. Plerixafor for the Treatment of WHIM Syndrome.
McDermott DH; Pastrana DV; Calvo KR; Pittaluga S; Velez D; Cho E; Liu Q; Trout HH; Neves JF; Gardner PJ; Bianchi DA; Blair EA; Landon EM; Silva SL; Buck CB; Murphy PM
N Engl J Med; 2019 Jan; 380(2):163-170. PubMed ID: 30625055
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Model Mice.
Majumdar S; Gao JL; Pontejo SM; Balabanian K; Bachelerie F; Murphy PM
Immunohorizons; 2022 Jul; 6(7):543-558. PubMed ID: 35882421
[TBL] [Abstract][Full Text] [Related]
24. WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.
Heusinkveld LE; Majumdar S; Gao JL; McDermott DH; Murphy PM
J Clin Immunol; 2019 Aug; 39(6):532-556. PubMed ID: 31313072
[TBL] [Abstract][Full Text] [Related]
25. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
Bachelerie F
Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
[TBL] [Abstract][Full Text] [Related]
26. Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.
Alapi K; Erdos M; Kovács G; Maródi L
Eur J Haematol; 2007 Jan; 78(1):86-8. PubMed ID: 17087743
[TBL] [Abstract][Full Text] [Related]
27. WHIM syndrome: congenital immune deficiency disease.
Kawai T; Malech HL
Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
[TBL] [Abstract][Full Text] [Related]
28. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
[TBL] [Abstract][Full Text] [Related]
29. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
[TBL] [Abstract][Full Text] [Related]
30. [Early detection of WHIM symdrome. A case report].
Macías-Robles AP; Tlacuilo-Parra A; Asencio-Gallegos AE; de la Herrán-Arita BK; Lugo-Reyes SO
Rev Alerg Mex; 2023 May; 70(1):47-50. PubMed ID: 37566756
[TBL] [Abstract][Full Text] [Related]
31. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.
McDermott DH; Liu Q; Ulrick J; Kwatemaa N; Anaya-O'Brien S; Penzak SR; Filho JO; Priel DA; Kelly C; Garofalo M; Littel P; Marquesen MM; Hilligoss D; Decastro R; Fleisher TA; Kuhns DB; Malech HL; Murphy PM
Blood; 2011 Nov; 118(18):4957-62. PubMed ID: 21890643
[TBL] [Abstract][Full Text] [Related]
32. The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
Wang L; Xiong Q; Li P; Chen G; Tariq N; Wu C
BMC Mol Cell Biol; 2021 Jan; 22(1):8. PubMed ID: 33485325
[TBL] [Abstract][Full Text] [Related]
33. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
34. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
[TBL] [Abstract][Full Text] [Related]
35. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
[TBL] [Abstract][Full Text] [Related]
36. [Late diagnosis of WHIM sydrome].
Paolini MV; Danielian S; Prieto E; Tami MF; Oleastro MM; Fernández Romero DS
Medicina (B Aires); 2018; 78(2):123-126. PubMed ID: 29659363
[TBL] [Abstract][Full Text] [Related]
37. WHIM syndrome: a genetic disorder of leukocyte trafficking.
Gulino AV
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):443-50. PubMed ID: 14612668
[TBL] [Abstract][Full Text] [Related]
38. [WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear].
Bock I; Dugué F; Loppinet E; Bellanné-Chantelot C; Bénet B
Ann Biol Clin (Paris); 2014; 72(1):111-9. PubMed ID: 24492099
[TBL] [Abstract][Full Text] [Related]
39. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
[TBL] [Abstract][Full Text] [Related]
40. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients.
Tassone L; Moratto D; Vermi W; De Francesco M; Notarangelo LD; Porta F; Lougaris V; Facchetti F; Plebani A; Badolato R
Blood; 2010 Dec; 116(23):4870-3. PubMed ID: 20736454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
